AwardTape · Defense awards · Research and development · Health R&D · W81XWH22C0046
W81XWH22C0046: $0 definitive contract to Cytosorbents Medical Inc
Cytosorbents Medical Inc holds a definitive contract from Defense Health Agency with $0 obligated since Oct 2023 and $4.3M obligated over its life, against a ceiling of $4.3M. Latest action Jun 1, 2026.
Award of cytosorbents DHA sbir ph iii med R&D contract for "integrating isoagglutinin reduction for a universal dried plasma product for battlefield and first responder use"
| PIID | W81XWH22C0046 |
|---|---|
| Type | definitive contract |
| Company | Cytosorbents Medical Inc |
| Agency | Defense Health Agency |
| Contracting office | ARMY MED RES ACQ ACTIVITY |
| Category | Research and development · Health R&D |
| PSC | AN11 HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| NAICS | 541715 RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| Obligated since Oct 2023 | $0 |
| Total obligated (lifetime) | $4.3M |
| Ceiling (base and all options) | $4.3M |
| Base date | Aug 22, 2022 |
| Latest action | Jun 1, 2026 |
| End date | Dec 21, 2026 |
| Actions since Oct 2023 | 3 |
| Pricing | Firm fixed price |
| Competition | Competed after exclusion of sources |
| Place of performance | NJ |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial